BARBARA LOTT: Open Payments
NPI 1982992921 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 26 payments from 7 companies in 2025. Trend: 2023 $331 · 2024 $219 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $256 |
| Astellas Pharma US Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Lilly USA, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: UBRELVY, VRAYLAR, QULIPTA, Veozah, XIFAXAN, MOUNJARO, Wegovy, NURTEC ODT.
Industry payments across WV — which companies pay providers there.
